Concerning the sensitivity of Acinetobacter calcoaceticus

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Acinetobacter calcoaceticus, var. anitratus (A. c. a.) is an opportunistic pathogen frequently isolated in nosocomial environments.
• Effective therapeutic strategies against A. c. a. infections are crucial due to its potential for antibiotic resistance.

Purpose of the Study:

• To evaluate the in vitro susceptibility of Acinetobacter calcoaceticus, var. anitratus strains to various antimicrobial agents.
• To identify effective therapeutic options and synergistic combinations for treating A. c. a. infections.

Main Methods:

• In vitro susceptibility testing of Acinetobacter calcoaceticus, var. anitratus isolates.
• Evaluation of individual antimicrobial agents and drug combinations.

Main Results:

• Third-generation cephalosporins, such as cefotaxime, demonstrated therapeutic potential.
• Combinations of amoxicillin or ticarcillin with clavulanic acid showed good efficacy.
• The combination of ticarcillin and amikacin exhibited the most significant synergistic effect.

Conclusions:

• In vitro data suggest viable therapeutic options for Acinetobacter calcoaceticus, var. anitratus infections.
• Antimicrobial combinations, particularly ticarcillin-amikacin, offer promising synergistic activity.
• Tailored therapy based on in vitro testing is recommended for optimal treatment outcomes.